Speaking in Philadelphia on Tuesday, Gov. Josh Shapiro highlighted the investments that the 2026-27 budget is making in innovation, including $125 million to create “Innovate in PA 2.0.”
The program provides $125 million in funding to support key technology-driven sectors across the Commonwealth, including life sciences, robotics, advanced manufacturing, and agriculture.
“Pennsylvania has always been a place where big ideas become world-changing innovations, and with this budget, we’re making sure the next generation of breakthroughs happen right here in the Commonwealth,” said Shapiro. “Innovate in PA 2.0 will help promising startups grow, strengthen our life sciences ecosystem, and connect more Pennsylvanians to good-paying jobs that will define the future. From biotech and robotics to advanced manufacturing and energy, we’re making strategic investments that help Pennsylvania compete, win, and lead the nation in innovation.”
Innovate in PA 2.0 is designed to bridge the gap between early-stage research and globally competitive commercial businesses. Its key initiatives would provide direct funding and financial resources for promising technology and life science startups, fund clinical trials to advance biotech and medical breakthroughs, and enhance the Commonwealth’s broader innovation network and fostering workforce development.
“This budget is a commitment to the quality of the people in Philadelphia and to the quality of innovation that happens in Philadelphia and across the Commonwealth — and that’s what leadership is, a trust in our people to give them the tools and resources needed to move forward,” said Matthew Burkhardt, Director of B+labs, one of Philadelphia’s life science incubators. “I look forward to seeing how this will capitalize the activity here in Philadelphia — and in Pittsburgh — and what it’ll mean for the companies and scientists that operate here.”
The Governor was also joined for a ceremonial bill signing at the event by Madeline Bell, CEO of Children’s Hospital of Philadelphia (CHOP); Jim Snell, Business Manager of Steamfitters Local 420; and Chris Molineaux, President and CEO of Life Sciences PA, the statewide trade group for the pharmaceutical and biotech industries.
“As the first children’s hospital in the country, innovation is core to who we are, and our CHOP team has been making incredible scientific breakthroughs for more than 170 years,” said Bell. “Every scientific breakthrough begins with a great idea, but it takes funding and teamwork to turn potential into progress — that’s why Innovate in PA 2.0 is so important.”
“To see Pennsylvania’s life science industry continue to grow, working to cure diseases, is tremendous, but there’s another angle to it — because these new buildings also mean job security for the Building Trades,” said Snell.”
“We have about 963 member companies across the Commonwealth with 376 of those companies being start ups. It is a vibrant ecosystem that is truly unmatched across the country, but the last three years have been difficult for start ups raising capital,” said Molineaux. Life Sciences PA represents the entire life sciences industry — biotechnology, diagnostic, medical device, and pharmaceutical companies; investment organizations; and research institutions.
“Now, Innovate in PA 2.0 is a true differentiator for Pennsylvania.